Relationship between -181 (A/G) region single nucleotide polymorphisms of matrilysin gene promoter and the onset and prevalence of colorectal cancer using tetra-primer ARMS PCR and RFLP-PCR techniques
,
Abstract
Aim: MMP enzymes are a family of membrane proteins that are capable of digesting extracellular matrix compounds (ECM) and basement membrane. Matrilysin enzyme is the smallest member of MMP family that is encoded by MMP-7 gene (matrilysin). According to the reports, G allele of -181 A/G single nucleotide polymorphism of MMP-7 gene causes an increase in the expression of this enzyme. This study aims to investigate the effect of promoter single nucleotide polymorphism of this gene on the colorectal cancer and compare the accuracy of tetra-primer ARMS PCR technique using RFLP-PCR technique.Methods: In this study, genomic DNA was extracted from total blood of 61 patients with colorectal cancer and 77 healthy subjects as controls. They were genotyped by tetra-primer ARMS PCR technique. A number of randomly selected samples were later genotyped by RFLP-PCR technique.Results: : As expected, the results of RFLP-PCR technique confirmed the results of tetra-primer ARMS technique. Results of this study showed no statistical association between this polymorphism and risk of initiation and metastasis of the colorectal cancer in the population of Isfahan.Conclusion: ATetra-primer ARMS technique can be used as an efficient clinical technique.Markowitz SD, Bertagnolli MM. 2009. Molecular basis of colorectal cancer. New England Journal of Medicine 361: 2449-2460.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer 127: 2893-2917.
Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R. 2009. Epidemiology and molecular genetics of colorectal cancer in Iran: a review. Arch Iran Med 12: 161-169.
John, A. and Tuszynsky, G. (2001) The role of matrix metalloproteinase in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res.; 1: 14-23.
Woessner J. 1998. The matrix metalloproteinase family. Matrix metalloproteinases: 1-14.
Sorsa, T., Salo, T. and Koivunen, E. (1997) Activation of type IV procollagenases by human tumor-associated trypsin-2. J. Biol. Chem.; 272:21067-21074.
Cawston, T. E., A. J. Barret and G. Salveson (1986) Inhibitors of metalloproteinases. Amersterdam.; 9: 589-610
Brinckerhoff, C. E. and Matrisian, L. M. (2002). Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol.; 3: 207-214.
Visse, F., Nagase, H. (2003) Structure and function of MMPs and TIMPs. Circulation Res.; 92:827-839.
Johansson, N., Ahonen, M. and Kähäri, V. –M. (2000) Matrix metalloproteinases in tumor invasion. Cell Mol. Life Sci.; 57: 5-15.
Zeng ZS, Shu WP, Cohen AM, Guillem JG. 2002. Matrix Metalloproteinase-7 Expression inColorectal Cancer Liver Metastases Evidence for Involvement of MMP-7 Activation in Human Cancer Metastases. Clinical Cancer Research 8: 144-148.
Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. 2006. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Experimental Biology and Medicine 231: 20-27.
Wells A. 2006. cell motility in cancerinvasion and metastasis. springer.
Nakamura M, Miyamoto S, Maeda H, Ishii G, Hasebe T, Chiba T, Asaka M, Ochiai A. 2005. Matrix metalloproteinase-7 degrades all insulinlike growth factor binding proteins and facilitates insulin-like growth factor bioavailability. . Biochem Biophys Res Commun 333: 1011–1016.
Almendro V, Ametller E, García-Recio S, Collazo O, Casas I, Augé JM, Maurel J, Gascón P. 2009. The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin. PLoS One 4: e4728.
Jormsjö S, Whatling C, Walter DH, Zeiher AM, Hamsten A, Eriksson P. 2001. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arteriosclerosis, thrombosis, and vascular biology 21: 1834-1839.
Lièvre A, Milet J, Carayol J, Le Corre D, Milan C, Pariente A, Nalet B, Lafon J, Faivre J, Bonithon-Kopp C. 2006. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. BMC cancer 6: 270.
McDonnell S, Navre M, Coffey RJ, Matrisian LM. 1991. Expression and localization of the matrix metalloproteinase pump‐1 (MMP‐7) in human gastric and colon carcinomas. Molecular carcinogenesis 4: 527-533.
Adachi Y, Yamamoto H, Itoh F, Hinoda Y, Okada Y, Imai K. 1999. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 45: 252-258.
Luo H, Zhou Z, Yang L, Yu Y, Tian C, Zhou B, Zheng XL, Xia Q, Li Y, Wang R. 2005. Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer. Japanese journal of clinical oncology 35: 739-744.
Zhang J, Jin X, Fang S, Wang R, Li Y, Wang N, Guo W, Wang Y, Wen D, Wei L. 2005. The functional polymorphismin the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 26: 1748-1753.
Vairaktaris E, Serefoglou Z, Yapijakis C, Vylliotis A, Nkenke E, Derka S, Vassiliou S, Avgoustidis D, Neukam FW. 2007. High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer. Anticancer research 27: 2493-2498.
Langers AMJ, Verspaget HW, Hommes DW, Sier CFM. 2011. Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer. World journalof gastrointestinal oncology 3: 79.
Ghilardi G, Biondi ML, Erario M, Guagnellini E, Scorza R. 2003. Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms. Clinical chemistry 49: 1940-1942.
Koskensalo S, Louhimo J, Nordling S, Hagström J, Haglund C. 2011. MMP-7 as a prognostic marker in colorectal cancer. Tumor Biology 32: 259-264.
Miller S A, Dykes D D. and Polesky H F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research.1998; 16:1215.27.
Sugimoto M, Furuta T, Kodaira C, Nishino M, Yamade M, Ikuma M, Sugimura H and Hishida A. Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan. J Gastroenterol. 2008; 43:751–761.
de Lima JM, de Souza LG, da Silva ID and Forones NM. E-cadherin and metalloproteinase-1 and -7 polymorphisms in colorectal cancer. Int J Biol Markers. 2009; 24:99–106.
Woo M, Park K, Nam J and Kim JC. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J. Gastroenterol Hepatol. 2007; 22:1064–1070.
Ohtani H, Maeda N and Murawaki Y. Functional polymorphisms in the promoter regions of matrix metalloproteinase-2,-3,-7,-9 and TNF-alpha Genes, and the risk of colorectal neoplasm in Japanese. Yonago Acta Med. 2009; 52:47–56.
Fang WL, Liang WB, He H, Zhu Y, Li SL, Gao LB and Zhang L. Association of matrix metalloproteinases 1, 7, and 9 gene polymorphisms with genetic susceptibility to colorectal carcinoma in a Han Chinese population. DNA Cell Biol. 2010; 29:657–661.
Kubben FJ, Sier CF, Meijer MJ, van den Berg M, van der Reijden JJ, Griffioen G, van de Velde CJ, Lamers CB and Verspaget HW. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer. 2006; 95:744–751.
| Files | ||
| Issue | Vol 7 No 2&3 (2015) | |
| Section | Original Articles | |
| Keywords | ||
| MMP7 gene colorectal cancer RFLP-PCR technique tetra-primer ARMS PCR technique | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
